Text Only Version A A A

bpas comment on RCOG, FSRH and BMS statement on contraception of HRT and contraception shortages

Clare Murphy, Director of External Affairs at bpas, said:

“We know some women have been struggling to access their preferred pill, and others have also experienced issues obtaining the contraceptive injection. It can take women a long time to find a pill that suits them and they may find it hard to tolerate the side effects they report on the others, including abdominal pain, headaches and irregular bleeding. Combined with the fact that emergency contraception is increasingly hard to obtain for free in England, it is not surprising that we are seeing unplanned pregnancies as a result.  We echo calls for an investigation into the shortages and urge the Secretary of State for Health to consider the reclassification of emergency contraception, so it can be sold straight from the shelf at a more affordable price to the women who need it.”


For more information, please call 07788 725 185 or email press@bpas.org.

About bpas

bpas is a charity which sees nearly 100,000 women a year for reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice. BPAS also runs the Centre for Reproductive Research and Communication, which seeks to develop and deliver a research agenda that furthers women’s access to evidence-based reproductive healthcare, driven by an understanding of women’s perspectives and needs. You can find out more here: https://www.bpas.org/get-involved/centre-for-reproductive-research-communication/